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Summary
Objective: To identify biochemical markers of osteoarthritis (OA) in the guinea pig, we characterized four biomarkers and 17 cytokines for age-
and strain-related differences.
Methods: Two guinea pig strains were examined in this study: (1) the Hartley (OA-prone) and (2) Strain 13 (OA-resistant). Levels of synovial
ﬂuid keratan sulfate (KS) and cartilage oligomeric matrix protein (COMP), as well as levels of serum C2C, CPII, and a panel of cytokines and
chemokines were quantiﬁed in both guinea pig strains. These included: IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-12p70, IL-17,
G-CSF, GM-CSF, IFN-g, KC, MIP-1a, RANTES, and TNF-a.
Results: Synovial ﬂuid concentrations of KS and COMP increased coincident with histological OA and correlated positively with the severity of
histological damage in both strains. Synovial ﬂuid concentrations of these biomarkers were elevated in the knees of the Hartley compared to
the Strain 13 animals, as early as 2 months of age. From as early as 4 months of age, the levels of serum C2C/CPII, representing the ratio of
type II collagen degradation and synthesis, were elevated in the OA-prone Hartley compared with Strain 13 animals. Also, at 12 months of
age, strain-related differences were apparent for 11 of the 16 cytokines and chemokines. Using multiple linear regression, serum IL-6 and
TNF-a concentrations were each strongly associated with strain, weight, and their interaction (r2¼ 0.80, P¼ 0.0002 for IL-6; r2¼ 0.55,
P¼ 0.02 for TNF-a).
Conclusions: Biomarkers derived from synovial ﬂuid are reﬂective of histological severity in the spontaneous model of OA in the guinea pig.
The synovial ﬂuid biomarker proﬁles indicated accelerated cartilage matrix turnover in the Hartley strain as early as 2 months of age, prior to
evidence of histological damage. The Hartley strain also exempliﬁed an imbalance in type II collagen metabolism and a serum cytokine/che-
mokine proﬁle indicative of a pro-inﬂammatory state. These ﬁndings elucidate additional disease-related features in the guinea pig that have
relevance to OA in humans.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
Through both animal and human studies, efforts have con-
tinued to identify biomarkers that are speciﬁc for osteoarthri-
tis (OA). OA-related biomarkers can complement, and
maybe someday substitute for, histological and imaging as-
sessments of disease progression or response to therapeu-
tic interventions. In order for biomarkers to be useful, it is
important that they be validated. Many factors inﬂuence bio-
marker concentrations1 and animal models provide a less
complex system than humans in which to validate and as-
sess the utility of OA-related biomarkers.
TheHartley guineapig is awell-characterizedmodel of nat-
urally occurringOA inwhich thedevelopment of knee joint pa-
thology closely resembles that in humans2e4.We discovered
previously that the inbred Strain 13 guinea pig isOA-resistant
relative to the OA-prone Hartley guinea pig, and thus pro-
vides a valuable age-matched control to the Hartley strain4.
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Received 28 December 2005; revision accepted 11 March 2006.9In the current study, we characterized guinea pigs of both
strains and of varying ages to evaluate the discriminating
capabilities of four biomarkers and 17 cytokines for OA.
Among the four biomarkers, we evaluated keratan sulfate
(KS) and cartilage oligomeric matrix protein (COMP) in syno-
vial ﬂuid to assess localizedmatrix turnover, diseaseprogres-
sion, and association with histological OA. KS is a sulfated
glycosaminoglycan component of aggrecan, the second
most abundant protein in articular cartilage. COMP is amem-
ber of the thrombospondin family of extracellular proteins and
is abundantly expressed in human cartilage5. The develop-
ment of speciﬁc antibodies to KSandCOMPhasmade it pos-
sible to assess cartilage metabolism at a molecular level. In
this way, synovial ﬂuid concentrations of KS and COMP
have been validated as biomarkers of joint tissue turnover
in animals6e10, as well as in patients with arthritis11e13.
C2C (Col2-3/4C longmono) is amarker of cartilage degrada-
tionwhich speciﬁcally recognizes the carboxy-terminus of the
three-quarter length fragment of type II collagen14. This
collagenase-generated cleavage epitope has been shown
to be elevated in serum, synovial ﬂuid, and urine in a model
of experimental OA in the dog15, suggesting its utility as
a marker of joint tissue degradation that is capable of
detecting early stages of type II collagen catabolism. CPII
(C-propeptide) is amarker of type II collagen synthesis, mea-
suring the carboxy-propeptide cleaved during processing of23
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shown to be decreased in serum in OA16. A panel of 17 cyto-
kines and chemokines in the serumwasevaluated to quantify
potential systemic indicators of OA. A predeﬁned, commer-
cially available mouse multiplex assay was utilized to permit
the simultaneous analysis of OA-related analytes (IL-1, IL-6,
IL-17, MIP-1a, and TNF-a) using a minimal volume of sera.
To our knowledge, there have been no previous assess-
ments of cytokines and chemokines in the guinea pig model
of OA.
Materials and methods
GUINEA PIG STRAINS
Two guinea pig strains were examined in this study: the
Hartley strain guinea pigs (OA-prone) were obtained from
Charles River Laboratories (Wilmington, MA) at 2 months
of age and sacriﬁced at 2, 4, 7, 10, and 12 months of age
(n¼ 6 per group). A different group of 2 (n¼ 3) and 12
(n¼ 8) month-old Hartley and Strain 13 animals were inves-
tigated to expand upon the characterization of strain-related
differences in the development of OA, initially reported in
a previous study4. The Strain 13 guinea pigs (OA-resistant)
were obtained from Crest Caviary (Prunedale, CA) at 2
(n¼ 3) and 12 (n¼ 8) months of age. Animals were housed
in solid bottom cages and fed water ad libitum and standard
guinea pig chow (Purina Lab Diet 5025) containing Vitamin C
(1 mg/g) and Vitamin D3 (3.4 IU/g). All animals were accli-
mated to housing conditions for 1 week prior to sample col-
lection. The Institutional Animal Care and Use Committee
approved all aspects of this study.
SAMPLE COLLECTION
Blood samples were obtained from guinea pigs under iso-
ﬂurane anesthesia via cardiac puncture and collected in
SST Brand Gel and Clot Activator Vacutainer tubes
(VWR, Morrisville, NC). Blood samples were centrifuged
at 3500 rpm for 10 min and serum stored in 1 ml aliquots
at 80(C until analyzed. Synovial ﬂuid was collected from
each knee joint as described previously4 and stored at
80(C until analyzed.
HISTOLOGICAL ANALYSES
The knee joints were prepared for histological analyses as
described previously10. Parafﬁnized sections (5 mM) of the
central region of the joint were stained with toluidine blue
and grading of serial sections of each knee was performed in-
dependently by two blinded observers (JLH, VBK) using
a modiﬁed Mankin grading scheme4. Histological evidence
of chondropathywasassessedbygradingof articular cartilage
structure (irregularities such as ﬁbrillation, the presence of
clefts, and loss of cartilage [0e8]), and proteoglycan loss (as
determined by loss of toluidine blue staining [0e6]). The sum
of articular cartilage structure and proteoglycan loss was tabu-
lated for the tibial and femoral condyles for themedial compart-
ment, the lateral compartment, and thewhole joint (medial and
lateral compartments). The possible total score for each com-
partment ranged from 0 (normal) to 14 (severe structural
damage and complete loss of toluidine blue staining), hence
the possible whole joint score ranged from 0 to 56.
BIOMARKER ANALYSES
Synovial ﬂuid concentrations of KS were measured using
monoclonal antibody 5-D-4 (kindly provided by Dr BruceCaterson, Cardiff, Wales) in a quantitative inhibition
enzyme-linked immunosorbent assay (ELISA) as described
previously4. This antibody reacts against several repeats of
a highly sulfated heptasaccharide in KS, a glycosaminogly-
can found in cartilage proteoglycans17. Levels of 5-D-4 KS
epitope were reported in terms of equivalents of an interna-
tional standard known as KS2 (kindly provided by Dr
Eugene Thonar, Chicago, IL) and expressed in nanograms
per milliliter. Intra- and inter-assay variabilities were 3.8%
and 4.1%, respectively.
Synovial ﬂuid concentrations of COMP were measured
by competitive ELISA using monoclonal antibody 12C4
(kindly provided by Dr Vladimir Vilim, Prague, Czech Re-
public), which cross reacts to guinea pig COMP, as de-
scribed previously10. This antibody recognizes an epitope
at the beginning of the carboxy-terminal globular domain
of human COMP18. Intra- and inter-assay variabilities
were 2.3% and 5.9%, respectively.
Serum concentrations of C2C and CPII were quantiﬁed
using commercially available kits from IBEX (Montreal,
CAN) according to the manufacturer’s instructions. The
intra- and inter-assay variabilities for C2C were 3.3% and
16.3%, respectively, and for CPII, 3.3% and 8.1%, respec-
tively. The ratio of C2C/CPII was calculated as an expres-
sion of the relative balance between type II collagen
degradation and synthesis. This method has been shown
to be more predictive of OA progression than either of the
individual markers of synthesis and degradation19.
Cytokines and chemokines in the serum were measured
using the Bio-Plex Protein Array System with the Bio-Plex
Mouse cytokine 18-Plex Panel including: interleukin-1alpha
(IL-1a), IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, KC (a murine IL-8
homologue), IL-10, IL-12p40, IL-12p70, IL-17, granulocyte
colony-stimulating factor (G-CSF), granulocyte macrophage
colony-stimulating factor (GM-CSF), interferon gamma
(IFN-g), macrophage inﬂammation protein 1 alpha (MIP-
1a), RANTES (regulated upon activation, normal T cell ex-
pressed and secreted), and tumor necrosis factor alpha
(TNF-a) (Bio-Rad, Hercules, CA). All samples were ana-
lyzed as recommended by the manufacturer using a stan-
dard range of 0e3200 pg/ml and a sample dilution of 1:2;
utilizing a total of 30 ml of sera. For 16 of the 18 cytokines
and chemokines measured, a measurable signal was ob-
tained. Sera levels of both IL-1a and IL-4 were below the
detection limit of the assay. Due to the limited quantities
of guinea pig synovial ﬂuid from knee joints, it was only pos-
sible to assess these cytokines and chemokines in the
serum.
STATISTICAL ANALYSES
Nonparametric KruskaleWallis test followed by Dunn’s
multiple comparison post test was used to assess for differ-
ences in biomarker concentrations in the Hartley strain at
various ages. The nonparametric ManneWhitney test was
used to compare the two guinea pig strains at 2 and 12
months of age. Data analyses were performed using Graph
Pad PRISM. A P-value of 0.05 was considered statisti-
cally signiﬁcant. Standard correlation analyses and linear
regression were performed using JMP Discovery software
(SAS, Cary, NC).
Results
A cross-sectional analysis of the Hartley guinea pig strain
revealed onset of histological knee OA by 4 months of age
925Osteoarthritis and Cartilage Vol. 14, No. 9with a steady increase in histological OA severity from 4 to 12
months of age (Fig. 1). Signiﬁcant differences in the whole
joint histological OA severity scores between age groups
(n¼ 6 per group) were apparent for animals from 4 to 7
months of age (P¼ 0.02), from 4 to 10 months of age
(P¼ 0.0005), from 4 to 12 months of age (P¼ 0.0001), and
from 7 to 12 months of age (P¼ 0.01). Comparison of the
two guinea pig strains demonstrated that the 12-month-old
Strain 13 guinea pigs had signiﬁcantly less severe histolog-
ical OA than the age-matched Hartley strain, as we previ-
ously reported4. The mean whole joint histological score for
the Strain 13 animals at 12 months of age was comparable
to the Hartley strain mean score at 7 months of age (Fig. 1).
We quantiﬁed synovial ﬂuid concentrations of KS and
COMP, serum concentrations of C2C and CPII, and serum
concentrations of a panel of cytokines and chemokines.
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Fig. 1. Histological progression of OA from 4 to 12 months of age in
the Hartley guinea pig. The dashed line represents the mean total
histological score of the 12-month-old Strain 13 guinea pigs.Synovial ﬂuid concentrations of both KS and COMP in-
creased with age [Fig. 2(A and C)] and correlated positively
with the severity of histological damage in the whole joint
from 4 to 12 months of age in the Hartley guinea pig (KS:
r2¼ 0.732, P¼ 0.0001; COMP: r2¼ 0.569, P¼ 0.005). The
proﬁles of these biomarkers were examined in both guinea
pig strains at 2 months of age, prior to the development of
histological OA, and at 12 months of age, after the appear-
ance of OA in all Hartley animals, to evaluate for differences
in cartilage turnover and metabolism between strains
[Fig. 2(B and D)]. Mean concentrations of synovial ﬂuid
KS differed signiﬁcantly within a strain from 2 to 12 months
of age for both the Hartley (P< 0.001) and Strain 13
(P¼ 0.06) animals. Mean concentrations of KS differed sig-
niﬁcantly between strains at 2 (P¼ 0.02) and 12 (P¼ 0.005)
months of age with higher concentrations in the Hartley
strain. In 12-month-old animals, KS concentrations corre-
lated with whole joint histological scores (r2¼ 0.574,
P¼ 0.02) and with many of the individual histological fea-
tures of OA including cartilage structure and proteoglycan
loss (Table I). Mean concentrations of synovial ﬂuid
COMP also increased with age for both the Hartley and
Strain 13 guinea pigs. At 2 months of age, synovial ﬂuid
COMP differed signiﬁcantly between strains (P¼ 0.05).
Similarly, at 12 months, the Hartley animals had higher
levels of synovial ﬂuid COMP compared to the age-
matched Strain 13 animals, although this trend was not sta-
tistically signiﬁcant (P¼ 0.09). In 12-month-old animals,
COMP concentrations correlated with cartilage structure de-
generation of the medial tibial plateau (Table I).
Concentrations of serum KS were also compared in the
Hartley and Strain 13 guinea pigs at 2 and 12 months of
age (data not shown). Although the levels of serum KS at
2 months of age were signiﬁcantly higher in the HartleySF
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Fig. 2. Synovial ﬂuid concentrations of KS and COMP in the Hartley strain from 4 to 12 months of age (A and C) and in Hartley (H) and Strain
13 (S) guinea pigs at 2 and 12 months of age (B and D). The asterisk (*) denotes a P-value <0.05 compared to the age-matched Strain 13.
The data for KS in (B) have been previously reported4 but are included here to enhance the interpretation of the data as a whole.
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Correlations of biomarkers to histological OA features within two guinea pig strains at 12 months of age
Site r2 (P-value)
SF KS SF COMP sC2C sCPII sC2C/CPII
Total score
Medial tibia 0.535 (0.03) 0.544 (0.04) 0.620 (0.01) 0.433 (0.12) 0.616 (0.02)
Medial femur 0.259 (0.33) 0.235 (0.42) 0.062 (0.83) 0.575 (0.02) 0.314 (0.26)
Whole joint 0.574 (0.02) 0.336 (0.24) 0.443 (0.10) 0.333 (0.23) 0.408 (0.13)
Cartilage structure
Medial tibia 0.523 (0.04) 0.538 (0.05) 0.673 (0.01) 0.368 (0.18) 0.612 (0.02)
Medial femur 0.509 (0.04) 0.161 (0.58) 0.064 (0.82) 0.476 (0.07) 0.238 (0.39)
Whole joint 0.620 (0.01) 0.410 (0.15) 0.566 (0.03) 0.323 (0.24) 0.490 (0.06)
Proteoglycan loss
Medial tibia 0.528 (0.04) 0.519 (0.06) 0.459 (0.09) 0.548 (0.03) 0.580 (0.02)
Medial femur 0.038 (0.89) 0.191 (0.51) 0.047 (0.87) 0.510 (0.06) 0.291 (0.29)
Whole joint 0.352 (0.18) 0.118 (0.69) 0.194 (0.49) 0.315 (0.25) 0.230 (0.41)
SF¼ synovial ﬂuid and s¼ serum.compared to the Strain 13 animals (P< 0.0001), in contrast
to synovial ﬂuid KS, this difference did not remain statisti-
cally signiﬁcant at 12 months of age (P¼ 0.63), when histo-
logical differences between strains were robust.
There were no differences in the mean concentrations of
serum C2C or CPII coincident with the development of his-
tological OA in the Hartley strain from 4 to 12 months of age
[Fig. 3(A and C)]. However, serum concentrations of C2C
throughout the period of OA development in the Hartley
strain (4e12 months), were consistently higher than con-
centrations in Strain 13 animals [compare Fig. 3(A) to
(B)]; serum CPII concentrations in the Hartley strain were
consistently lower than in Strain 13 animals [compare
Fig. 3(C) to (D)]. At 12 months of age, these differences be-
tween strains were signiﬁcantly different: (P¼ 0.0001 for
C2C, n¼ 8 each; and P¼ 0.02 for CPII, n¼ 8 each). Con-
sequently, the ratio of C2C/CPII was signiﬁcantly higher in
the Hartley strain compared to the age-matched Strain 13
(P¼ 0.0002 at 12 months of age), demonstrating an excess
of type II collagen catabolism relative to anabolism in the
Hartley strain guinea pig. Across strains, serum concentra-
tions of C2C and the C2C/CPII ratio correlated positively
with cartilage structure degeneration of the medial tibial pla-
teau (Table I).
The serum concentrations of a panel of cytokines and
chemokines tended to increase in the Hartley strain from
7 to 12 months of age (data not shown), although these
were not statistically signiﬁcant differences. Serum concen-
trations of this panel of cytokines and chemokines did not
differ between the two strains at 2 months of age (data
not shown); however, at 12 months of age, there were sig-
niﬁcant strain-related differences in 11 of the 16 cytokines/
chemokines measured. Mean serum concentrations of 10
of the 16 cytokines and chemokines were signiﬁcantly
higher in the 12-month-old Hartley guinea pigs compared
to the age-matched Strain 13 guinea pigs (Table II). Inter-
estingly, mean serum concentrations of RANTES followed
the opposite pattern, namely, RANTES concentrations
were signiﬁcantly lower in the Hartley guinea pig strain at
both time points (2 months: P¼ 0.001; 12 months:
P¼ 0.003) compared to the age-matched Strain 13
animals.
At 12 months of age, the Strain 13 guinea pigs were
smaller in size than the age-matched Hartley strain. We
found an association of animal weight and histological OA
(P¼ 0.016) as reported previously4, as well as strain (P¼
0.003). Multiple linear regression was performed to evaluatethe effects of weight and strain on histological manifesta-
tions of cartilage degeneration in the medial compartment
of the knee. There was no interaction between strain and
weight as predictors of histological OA (P¼ 0.21). After re-
moving the interaction term, together, weight and strain
were found to be predictive of histological OA (r2¼ 0.48,
P¼ 0.01). The differences in histological OA between the
two strains were predominantly inﬂuenced by strain differ-
ences (P¼ 0.09), rather than differences in body weight
(P¼ 0.95). We therefore further analyzed results for the
two cytokines associated with obesity in humans, IL-6 and
TNF-a20. In a multivariate model, cytokine concentrations,
weight, strain and the interaction term (weight strain)
were each independent predictors of IL-6 and TNF-a con-
centrations (r2¼ 0.80, P¼ 0.0002 for IL-6; r2¼ 0.55,
P¼ 0.02 for TNF-a).
Discussion
In this animal model of OA, concentrations of synovial
ﬂuid KS and COMP reﬂected histological OA severity,
both within the Hartley strain and between strains. These
data suggest that both of these biomarkers may be useful
for monitoring the progression of OA in this animal model.
Both of these biomarkers were elevated in the synovial ﬂuid
of the Hartley (relative to Strain 13) prior to detectable his-
tological OA at 2 months of age. Thus, synovial ﬂuid
COMP, in addition to synovial ﬂuid KS as previously re-
ported4, is identiﬁed as a biomarker that reﬂects early
strain-related differences in cartilage metabolism. Higher
concentrations of COMP in the synovial ﬂuid have been as-
sociated with OA in animals8e10 and human patients13,21. In
this study, we also observed an association of synovial ﬂuid
COMP with histological OA. Comparing strains, synovial
ﬂuid COMP was higher in the OA-prone Hartley compared
with the OA-resistant Strain 13 animals at 12 months of
age (P¼ 0.09), however, the relatively small number of an-
imals upon which these pilot experiments were based, likely
precluded the ability to detect a difference that was statisti-
cally signiﬁcant. KS in synovial ﬂuid was the marker that
yielded statistically signiﬁcant correlations with the greatest
number of histological measures and sites of degradation.
These data show that synovial ﬂuid KS is an excellent
global marker of disease while synovial ﬂuid COMP and
the collagen markers are more speciﬁc for structural
changes associated with OA. All of these markers have
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Fig. 3. Serum concentrations of C2C (A and B), CPII (C and D) and C2C/CPII (E and F) in the Hartley strain from 4 to 12 months of age (A, C,
and E) and in Hartley (H) and Strain 13 (S) guinea pigs at 2 and 12 months of age (B, D, and F). The asterisk (*) denotes a P-value <0.05
compared to the age-matched Strain 13.the potential to be useful for monitoring the response to
therapeutic interventions.
The concept that combiningmarkers of synthesis and deg-
radation to improve diagnostic sensitivity was suggested by
Otterness et al.22. Since then, two clinical studies have dem-
onstrated that the use of biomarkers, to account simulta-
neously for synthesis and degradation of cartilage, provides
greater predictive capability for OA progression19,23. The ra-
tio of serum C2C/CPII was higher in the OA-prone Hartley
strain guinea pigs relative to the OA-resistant Strain 13, indi-
cating an upregulation of collagen degradation in the
absence of a compensatory upregulation in collagen synthe-
sis between 2 and 12 months of age, and consequently an
imbalance of collagen II degradation and synthesis in the
OA-prone Hartley guinea pig. These alterations in collagen
metabolism within the Hartley strain appeared to occur at
a very early age. We previously described that the Hartleyalso displays high bone turnover from a young age4. These
data support the hypothesis that high boneand cartilage turn-
over are speciﬁc hallmarks of an early predisposition to OA in
the Hartley guinea pig.
It is possible that a high turnover rate of cartilage struc-
tures, including the growth plate, in the Hartley strain, may
mask the release of biomarkers into the serum that may
be reﬂective of OA processes occurring in the knee in this
spontaneous model. It is known that guinea pig bone
growth ceases at 4 months of age24, but the femoral and tib-
ial growth plates do not completely fuse until 2 years of
age25. Further investigation is needed to evaluate the utility
of these serum biomarkers in other model systems, such as
acute knee injury, that may be associated with more dra-
matic increases in these biomarkers and may therefore be
distinguished more readily from the background level of
type II collagen turnover. Based upon these results, we
928 J. L. Huebner and V. B. Kraus: Assessment of biomarkers in guinea pig modelwould conclude that KS and COMP in synovial ﬂuid are
likely to be most useful for monitoring response to therapeu-
tic interventions in the spontaneous model of OA in the
guinea pig.
Serum concentrations of a panel of cytokines and chemo-
kines were measured for the purpose of gaining information
about their role in the development of OA in this animal
model. It was fortuitous that the cytokines and chemokines
could be successfully measured, albeit using a kit designed
speciﬁcally for mouse sera. Although the range of values
obtained from the guinea pig sera samples were consis-
tently lower than those obtained from mouse samples
(data not shown), 16 of the 18 cytokines and chemokines
measured were readily detectable. Since the concentra-
tions were determined on the basis of mouse standards, it
is possible that the absolute values obtained are not accu-
rate. However, this limitation does not negate the utility of
these measures for evaluating the variation due to age
and strain in the guinea pig.
Comparison of serum concentrations of cytokines and
chemokines between the Hartley and age-matched Strain
13 guinea pigs revealed signiﬁcant differences. The Hartley
strain had signiﬁcantly higher levels of 10 of the cytokines
and chemokines compared to the age-matched Strain 13
at 12 months of age, demonstrating a pro-inﬂammatory
state in the Hartley compared to Strain 13. Among the cyto-
kines and chemokines elevated in the OA-prone Hartley,
several have been associated previously with OA including
IL-6, IL-17, IL-8, MIP-1a, and TNF-a26e28. It was unex-
pected that there was no difference between strains in
levels of IL-1b, as this has been identiﬁed as a catabolic cy-
tokine implicated in the pathogenesis of cartilage matrix
degradation in OA29,30. However, the lability of this cytokine
may have precluded making meaningful conclusions from
serum levels31.
These two guinea pig strains are similar in weight during
the ﬁrst 6 months of age and diverge thereafter, with
a mean 20% greater weight in the Hartley by 12 months of
age compared to Strain 1332. This difference might possibly
contribute to the pro-inﬂammatory state in the Hartley. It has
been reported in humans that obesity results in an inﬂamma-
tory state brought on by the production and release of
Table II
Serum cytokine/chemokine concentrations (pg/ml) in 12-month-old
Hartley (OA-prone) and Strain 13 (OA-resistant)
Cytokine Hartley (n¼ 8)
meanSD
Strain 13 (n¼ 8)
meanSD
P-valuey
IL-5 3.7 3.2 1.2 0.4 0.007
IL-17 9.0 9.1 2.6 0.8 0.015
IL-2 15.4 9.5 6.1 1.3 0.015
IL-12p40 14.3 18.1 3.6 1.7 0.021
KC 3.1 1.7 1.2 0.5 0.028
MIP-1a 37.0 15.7 19.1 6.4 0.028
IL-12p70 14.2 9.1 5.8 2.2 0.038
RANTES 20.6 12.0 67.4 35.8 0.038
GM-CSF 10.6 5.0 5.3 2.1 0.038
IL-6 15.5 8.6 8.5 3.1 0.050
G-CSF 4.7 3.1 2.0 0.6 0.050
TNF-a 137.6 83.5 72.9 23.5 0.065
IL-3 0.9 0.6 0.5 0.1 0.065
INFg 3.8 2.5 1.7 0.7 0.105
IL-10 19.1 8.6 12.0 2.9 0.130
IL-1b 45.4 14.4 43.0 8.5 0.798
yP-values were determined by ManneWhitney nonparametric
test.a variety of pro-inﬂammatory factors from adipose tissue33.
Obesity is an important risk factor for hand OA34. Given
that the effects of obesity on the development of OA of the
hand are nonmechanical, it suggests that a systemic factor
derived from fat mass may potentiate OA. Two of the ele-
vated cytokines measured in this study have been speciﬁ-
cally associated with the inﬂammatory state of obesity in
humans, namely IL-6 and TNF-a, both of which have been
directly correlated with adiposity20. We found the concentra-
tions of these two cytokines to be strongly predicted by
strain, weight, and an interaction of these two variables, con-
sistent with a complex involvement of connective tissue
metabolism, and inﬂammatory and mechanical factors in
the etiopathogenesis of OA in the guinea pig.
The synthesis of RANTES, a member of the CC chemo-
kine family, has been shown to be strongly upregulated by
pro-inﬂammatory cytokines26,27. Thus, another unexpected
result was that levels of RANTES were signiﬁcantly higher
in the OA-resistant, Strain 13 guinea pigs, compared to the
OA-prone Hartley guinea pigs. It has been reported that
RANTES is rarely expressed in normal adult human tissue,
but has been identiﬁed in synovial tissue, synovial ﬂuid,
and serum of patients with rheumatoid arthritis and
OA35,36. Conversely, a recent study reported only trace
amounts of RANTES in synovial ﬂuid from only two of ﬁve
OA patients37. RANTES has been shown to bind the proteo-
glycans, heparan sulfate and chondroitin sulfate38. Serum
proteoglycan (as reﬂected by serum KS) was elevated in
the Hartley relative to the Strain 13 animals. It is therefore
possible that RANTES may be effectively sequestered
from measurement in the Hartley as a result of binding to
synovial ﬂuid and serum proteoglycan. Alternatively,
RANTES may prove to be a novel indicator of metabolic
processes that may be protective in the OA process.
Our previous analyses comparing the two guinea pig
strains provided evidence for a role of altered metabolism
of both cartilage and bone in the OA-prone Hartley guinea
pig. The present study extends these observations and dem-
onstrates not only a predisposition toOA in theHartley strain,
but a failure of collagen synthesis (CPII) to be upregulated
from 2 to 12 months of age in the face of an increase of col-
lagen degradation (C2C), leading to an imbalance in colla-
gen degradation and synthesis that develops coincident
with disease. Moreover, to our knowledge, this is the ﬁrst de-
scription of cytokines and chemokines in the guinea pig
model of OA, demonstrating the development of an inﬂam-
matory proﬁle with the establishment of the disease in the
Hartley guinea pig. This intriguing observation invites further
investigation of the contributions and interrelationship of the
disease process and obesity in the establishment of this pro-
inﬂammatory state.
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